TY - JOUR
T1 - A single pot template reaction towards a manganese based T1 contrast agent
AU - Anbu, Sellamuthu
AU - Hoffmann, Sabrina
AU - Carniato, Fabio
AU - Kenning, Lawrence
AU - Price, Thomas
AU - Prior, Timothy J.
AU - Botta, Mauro
AU - Martins, Andre F.
AU - Stasiuk, Graeme
N1 - Funding Information:
S.A. gratefully acknowledges the Departments of Chemistry and Biomedical Sciences, the University of Hull, for providing laboratory space and instruments access to carrying out this work. The work has also been partially supported by the RSC Research Fund grant (RF19‐7464). G.J.S. would like to thank the MRC for funding (MR/T002573/1). A.F.M. gratefully acknowledges the funding and support by the Swiss Werner Siemens Foundation and the Faculty of Medicine at the University of Tuebingen (Nachwuchsgruppen‐Programm). The work was also funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy—EXC 2180‐390900677. M.B. and F.C. are grateful to Università del Piemonte Orientale for financial support (FARC 2019). We thank also Dr. Christoph Trautwein and Georgy Berezhnoy for assistance performing H NMR and relaxometric studies at the Bruker Spectrometer 14.1 T. 1
Funding Information:
S.A. gratefully acknowledges the Departments of Chemistry and Biomedical Sciences, the University of Hull, for providing laboratory space and instruments access to carrying out this work. The work has also been partially supported by the RSC Research Fund grant (RF19-7464). G.J.S. would like to thank the MRC for funding (MR/T002573/1). A.F.M. gratefully acknowledges the funding and support by the Swiss Werner Siemens Foundation and the Faculty of Medicine at the University of Tuebingen (Nachwuchsgruppen-Programm). The work was also funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy?EXC 2180-390900677. M.B. and F.C. are grateful to Universit? del Piemonte Orientale for financial support (FARC 2019). We thank also Dr. Christoph Trautwein and Georgy Berezhnoy for assistance performing 1H NMR and relaxometric studies at the Bruker Spectrometer 14.1 T.
Publisher Copyright:
© 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/5/3
Y1 - 2021/5/3
N2 - Manganese-based contrast agents (MnCAs) have emerged as suitable alternatives to gadolinium-based contrast agents (GdCAs). However, due to their kinetic lability and laborious synthetic procedures, only a few MnCAs have found clinical MRI application. In this work, we have employed a highly innovative single-pot template synthetic strategy to develop a MnCA, MnL
Me, and studied the most important physicochemical properties in vitro. MnL
Me displays optimized r
1 relaxivities at both medium (20 and 64 MHz) and high magnetic fields (300 and 400 MHz) and an enhanced r
1
b=21.1 mM
−1 s
−1 (20 MHz, 298 K, pH 7.4) upon binding to BSA (K
a=4.2×10
3 M
−1). In vivo studies show that MnL
Me is cleared intact into the bladder through renal excretion and has a prolonged blood half-life compared to the commercial GdCA Magnevist. MnL
Me shows great promise as a novel MRI contrast agent.
AB - Manganese-based contrast agents (MnCAs) have emerged as suitable alternatives to gadolinium-based contrast agents (GdCAs). However, due to their kinetic lability and laborious synthetic procedures, only a few MnCAs have found clinical MRI application. In this work, we have employed a highly innovative single-pot template synthetic strategy to develop a MnCA, MnL
Me, and studied the most important physicochemical properties in vitro. MnL
Me displays optimized r
1 relaxivities at both medium (20 and 64 MHz) and high magnetic fields (300 and 400 MHz) and an enhanced r
1
b=21.1 mM
−1 s
−1 (20 MHz, 298 K, pH 7.4) upon binding to BSA (K
a=4.2×10
3 M
−1). In vivo studies show that MnL
Me is cleared intact into the bladder through renal excretion and has a prolonged blood half-life compared to the commercial GdCA Magnevist. MnL
Me shows great promise as a novel MRI contrast agent.
UR - http://www.scopus.com/inward/record.url?scp=85103980307&partnerID=8YFLogxK
U2 - 10.1002/anie.202100885
DO - 10.1002/anie.202100885
M3 - Article
SN - 1433-7851
VL - 60
SP - 10736
EP - 10744
JO - ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
JF - ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
IS - 19
ER -